The arrival of Retatrutide ZPHC, at a concentration of 120mg, is generating considerable buzz within the medical community. This groundbreaking dual GIP and GLP-1 receptor medication appears to deliver impressive improvements in fat reduction compared to existing therapies. Early clinical data ha